Skip to main content
. 2012 Jan 31;34(1):30–38. doi: 10.1093/eurheartj/ehr504

Figure 3.

Figure 3

Effect of ferric carboxymaltose on Kansas City Cardiomyopathy Questionnaire overall summary score among pre-specified subgroups in the FAIR-HF study population. CHF, chronic heart failure; FCM, ferric carboxymaltose; GFR, glomerular filtration rate; HRQoL, health-related quality of life; KCCQ, Kansas City Cardiomyopathy Questionnaire; NYHA, New York Heart Association.